fotemustine has been researched along with Hematologic Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beauchesne, PD; Bernier, V; Carnin, C; Taillandier, L | 1 |
| Annesi, D; Ascierto, PA; Di Giacomo, AM; Ferrucci, PF; Fonsatti, E; Giannarelli, D; Maio, M; Marasco, A; Nicoletti, SV; Parmiani, G; Pilla, L; Queirolo, P; Ridolfi, R; Rivoltini, L; Santinami, M; Simeone, E; Testori, A | 1 |
| Aapro, MS; Beex, LV; Guastalla, JP; Kobierska, A; Namer, M; Rosso, R; Splinter, TE; ten Bokkel Huinink, W; van der Burg, ME; van Wijk, FH; Vergote, I; Vermorken, JB | 1 |
| Baio, S; Berille, J; Le Cesne, A; Le Chevalier, T; Rivière, A | 1 |
| Berille, J; Brune, J; Cotto, C; Croisile, B; Giroux, B; Riou, R; Souquet, PJ; Trillet-Lenoir, V; Turjman, F | 1 |
| Bleiberg, H; De Greve, J; Fabri, MC; Gerard, B; Kok, T; Paillot, B; Rougier, P; Van Glabbeke, M; van Pottelsberghe, C; Wagener, T | 1 |
| Aigner, K; Auclerc, G; Bizzari, JP; Borel, C; Bousquet, JC; Buthiau, D; Cohen-Alloro, G; Cour, V; Khayat, D; Weil, M | 1 |
1 review(s) available for fotemustine and Hematologic Diseases
| Article | Year |
|---|---|
Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II Study.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Remission Induction | 1991 |
7 trial(s) available for fotemustine and Hematologic Diseases
| Article | Year |
|---|---|
Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Female; Glioma; Hematologic Diseases; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Prospective Studies; Stereotaxic Techniques; Supratentorial Neoplasms; Survival Rate | 2009 |
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease-Free Survival; Female; Hematologic Diseases; Humans; Ipilimumab; Male; Melanoma; Middle Aged; Neoplasm Grading; Neoplasm Staging; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms | 2012 |
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group.
Topics: Adult; Aged; Antineoplastic Agents; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Middle Aged; Nausea; Nitrosourea Compounds; Organophosphorus Compounds; Ovarian Neoplasms; Vomiting | 2003 |
Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: preliminary report of a French multicentre phase II trial.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Nitrosourea Compounds; Organophosphorus Compounds; Vomiting | 1994 |
A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate | 1996 |
Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCCG (European Organization for Research and Treatment of Cancer, Gastrointestinal Tract Cancer Cooperative Group).
Topics: Adult; Aged; Antineoplastic Agents; Female; Hematologic Diseases; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Stomach Neoplasms; Treatment Outcome | 1996 |
Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II Study.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Remission Induction | 1991 |